Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: Neuromuscul Disord. 2018 Jun 27;28(9):778–786. doi: 10.1016/j.nmd.2018.06.007

Table 1.

Demographics, Primary outcomes: Questionnaires for functional capacity in Affected, Carrier and Unaffected relatives, Muscle strength measurement: 6 min walk test.

M/F Affected
17/11 (61% M, 39% F)
Mean (SD)
Carriers
2/5 (29% M, 71%F)
Mean (SD)
Unaffected relatives
7/7 (50% M, 50%F)
Mean (SD)
p-value*
Age (year)
(N = 28, 7, 14)
52.40 (8.96) 43.31 (7.53) 48.79 (14.86) 0.57, 0.13, 0.52
BMI (kg/m2)
(N = 24, 5, 9)
35.13 (26.17) 32.56 (10.95) 29.32 (4.89) 0.77, 0.97, 0.96
IBMFRS (N = 26,6,8)
(out of 40)
27.31 (9.54) 38.00 (2.45) 39.88 (0.35) 0.01, 0.02, 0.90
Fatigue scale (N = 24,4,9)
(out of 63)
45.29 (12.72) 34.50 (24.77) 26.89 (11.86) 0.02**
6 min walk test (m)
(N = 14,6,13)
390.86 (168.64) 458.13 (95.33) 550.82 (98.23) 0.02, 0.65, 0.49

Sample sizes (N) are listed in order of affected, carriers, and unaffected relatives.

*

p-values are indicated in the order of differences between affected and unaffected individuals, differences between affected individuals and carriers, and differences between carriers and unaffected individuals. p-values ≤ 0.05 indicate significant differences

**

Indicates difference between affected and unaffected. The small sample size of the group precluded statistical analysis of the carriers.